World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
9156
World Ranking
15228
National Ranking
6365

Overview

Glenda Kohlhagen is affiliated with the National Institutes of Health in the United States. Their professional activities are centered within this prominent federal biomedical research organization, which supports and conducts a broad spectrum of health-related research.

There is no public record of recent papers authored by Glenda Kohlhagen, and no data is available regarding specific research topics, fields of study, or subfields. Consequently, there are no detailed records of frequent publication venues, collaborations with co-authors, or specific scientific topics covered in their work.

No information is available about book publications authored or contributed to by Glenda Kohlhagen, nor is there data indicating awards or recognitions received. The profile reflects a focus on affiliation and professional positioning rather than specific academic outputs or accolades.

Given the affiliation with the National Institutes of Health, it is reasonable to contextualize their role within a wide array of biomedical and health science research endeavors, although precise details regarding their individual contributions or areas of specialization remain undocumented in the available data.

Best Publications

  • Inhibition of Histone Deacetylase Increases Cytotoxicity to Anticancer Drugs Targeting DNA

    Myoung Sook Kim;Mellissa Blake;Jin Hyen Baek;Glenda Kohlhagen

  • DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.

    Yves Pommier;Glenda Kohlhagen;Christian Bailly;Michael Waring

  • Repair of and checkpoint response to topoisomerase I-mediated DNA damage.

    Yves Pommier;Christophe Redon;V.Ashutosh Rao;Jennifer A Seiler

  • Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

    Mariafiorella Brangi;Thomas Litman;Marco Ciotti;Kenryu Nishiyama

  • Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol

    Bernard W. Parker;Gurmeet Kaur;Wilberto Nieves-Neira;Mohammed Taimi

  • Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors

    Yves Pommier;D. Pharm;Mark R. Fesen;Akira Fujimori

  • EFFECTS OF URACIL INCORPORATION, DNA MISMATCHES, AND ABASIC SITES ON CLEAVAGE AND RELIGATION ACTIVITIES OF MAMMALIAN TOPOISOMERASE I

    Philippe Pourquier;Li-Ming Ueng;Glenda Kohlhagen;Abhijit Mazumder

  • Human mitochondrial topoisomerase I.

    Hongliang Zhang;Juana M. Barceló;Benson Lee;Glenda Kohlhagen

  • Trapping of Mammalian Topoisomerase I and Recombinations Induced by Damaged DNA Containing Nicks or Gaps: IMPORTANCE OF DNA END PHOSPHORYLATION AND CAMPTOTHECIN EFFECTS *

    Philippe Pourquier;André A. Pilon;Glenda Kohlhagen;Abhijit Mazumder

  • Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.

    Isabelle Plo;Zhi Yong Liao;Juana M Barceló;Glenda Kohlhagen

  • The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.

    David Bom;Dennis P. Curran;Stefan Kruszewski;Stephen G. Zimmer

  • Mutation at the Catalytic Site of Topoisomerase I in CEM/C2, a Human Leukemia Cell Line Resistant to Camptothecin

    Fujimori A;Harker Wg;Kohlhagen G;Hoki Y

  • Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites

    Yves Pommier;Glenda Kohlhagen;Kurt W. Kohn;Francois Leteurtre

  • Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives

    Akihiko Tanizawa;Kurt W. Kohn;Glenda Kohlhagen;Francois Leteurtre

  • Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.

    Laurent Debéthune;Glenda Kohlhagen;Anna Grandas;Yves Pommier

  • Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.

    Philippe Pourquier;Yuji Takebayashi;Yoshimasa Urasaki;Christopher Gioffre

  • Characterization of a Novel Topoisomerase I Mutation from a Camptothecin-resistant Human Prostate Cancer Cell Line

    Yoshimasa Urasaki;Gary S. Laco;Phillipe Pourquier;Yuji Takebayashi

  • Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine), an Antimetabolite That Poisons Topoisomerase I

    Philippe Pourquier;Christopher Gioffre;Glenda Kohlhagen;Yoshimasa Urasaki

  • Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.

    Yuji Takebayashi;Philippe Pourquier;Akira Yoshida;Glenda Kohlhagen

  • Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.

    A Tanizawa;R Beitrand;G Kohlhagen;A Tabuchi

Frequent Co-Authors

Yves Pommier
Yves Pommier National Institutes of Health
Kurt W. Kohn
Kurt W. Kohn National Institutes of Health
Jane M. Sayer
Jane M. Sayer National Institutes of Health
Donald M. Jerina
Donald M. Jerina National Institutes of Health
Mansukh C. Wani
Mansukh C. Wani Research Triangle Park Foundation
David J. Adams
David J. Adams Wellcome Sanger Institute
Mark Cushman
Mark Cushman Purdue University West Lafayette
Isabelle Plo
Isabelle Plo University of Paris-Saclay
Susan E. Bates
Susan E. Bates Columbia University
Monroe E. Wall
Monroe E. Wall Research Triangle Park Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Glenda Kohlhagen